Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus

Recruiting now · Not applicable

Conditions studied: Systemic Lupus Erythematosus

In brief

The study aims at defining the role of ferroptosis s in the physiopathology of systemic lupus erythematosus (SLE). Ferroptosis (phenomenon of cellular death regulated by iron) is a metabolic pathway potentially implicated in SLE with potential for the discovery of new therapeutic strategies.

Key facts

Study ID

NCT07260942

Run by

University Hospital, Bordeaux

People needed

120

Starts

2026-04-21

Expected to finish

2029-04-01

Last updated by the study team

2026-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age ≥ 18 years;
• diagnosis of systemic lupus erythematosus;
• being affiliated to health insurance, willing to participate and to sign informed consent;
• control group : patients with a diagnosis of rheumatoid arthritis or an inflammatory bowel disease.

You may not qualify if…

• pregnant or breastfeeding women;
• patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).

Where it is running

• CHU de Bordeaux - service de rhumatologie — Bordeaux, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.